|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12N 15/113 | |
| C12Q 1/6813 | |||
| C12Q 1/6883 |
| (11) | Patento numeris | 3330383 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17194587.6 |
| Europos patento paraiškos padavimo data | 2009-10-13 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-06-06 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-02-12 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 106491 P | 2008-10-17 | US |
| (72) |
HARLEY, Calvin, B., US
ELIAS, Laurence, US
SMITH, Jennifer, US
RATAIN, Mark J., US
BENEDETTI, Fabio, US
|
| (73) |
Geron Corporation,
919 E. Hillsdale Blvd., Foster City, CA 94404,
US
|
| (54) | GRN163L FOR USE AS TELOMERASE INHIBITOR IN THE TREATMENT OF CANCER |
| GRN163L FOR USE AS TELOMERASE INHIBITOR IN THE TREATMENT OF CANCER |